HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.

AbstractBACKGROUND:
Spontaneous bacterial peritonitis (SBP) is historically caused by Gram-negative bacteria (GNB) almost exclusively Enterobacteriaceae. Recently, an increasing rate of infections with Gram-positive cocci (GPC) and multidrug-resistant (MDR) microorganisms was demonstrated.
AIMS:
To assess possible recent changes of the bacteria causing SBP in cirrhotic patients.
METHODS:
We retrospectively recorded 47 cases (66% males) during a 4-year-period (2008-2011).
RESULTS:
Twenty-eight (60%) patients had healthcare-associated infections while 15 (32%) received prophylactic quinolone treatment. GPC were found to be the most frequent cause (55%). The most prevalent organisms in a descending order were Streptococcus spp (n = 10), Enterococcus spp (n = 9), Escherichia coli (n = 8), Klebsiella pneumonia (n = 5), methicillin-sensitive Staphylococcus aureus (n = 4) and coagulase-negative Staphylococcus spp (n = 3). Nine of the isolated bacteria (19%) were MDR, including carbapenemase-producing K. pneumonia (n = 4), followed by extended-spectrum beta-lactamase-producing E. coli (n = 3) and Pseudomonas aeruginosa (n = 2). MDR bacteria were more frequently isolated in healthcare-associated than in community-acquired infections (100% vs 50%, P = 0.006), in patients receiving long-term quinolone prophylaxis (67% vs 24%, P = 0.013) and in those with advanced liver disease as suggested by higher MELD score (28 vs 19, P = 0.012). More infections with GNB than GPC were healthcare-associated (81% vs 42%, P = 0.007). Third-generation cephalosporin resistance was observed in 49% and quinolone resistance in 47%.
CONCLUSIONS:
GPC were the most frequent bacteria in culture-positive SBP and a variety of drug-resistant microorganisms have emerged. As a result of high rates of resistance in currently recommended therapy and prophylaxis, the choice of optimal antibiotic therapy is vital in the individual patient.
AuthorsAlexandra Alexopoulou, Nikolaos Papadopoulos, Dimitrios G Eliopoulos, Apostolia Alexaki, Athanasia Tsiriga, Marina Toutouza, Dimitrios Pectasides
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 33 Issue 7 Pg. 975-81 (Aug 2013) ISSN: 1478-3231 [Electronic] United States
PMID23522099 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Topics
  • Aged
  • Cross Infection (epidemiology, microbiology)
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Gram-Negative Bacteria
  • Gram-Positive Cocci
  • Greece (epidemiology)
  • Humans
  • Liver Cirrhosis (complications)
  • Male
  • Middle Aged
  • Peritonitis (epidemiology, etiology, microbiology)
  • Prevalence
  • Retrospective Studies
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: